COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Emerging efficacy data have led to the emergency use authorization or approval of COVID-
19 vaccines in several countries worldwide. Most trials of COVID-19 vaccines excluded …
19 vaccines in several countries worldwide. Most trials of COVID-19 vaccines excluded …
Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross …
J Hong, X Xu, J Yang, J Zheng, S Dai, J Zhou… - Journal of integrative …, 2022 - Elsevier
Objective The coronavirus disease 2019 (COVID-19) pandemic has had a serious impact on
health all over the world. Cancer patient, whose immunity is often compromised, faces a …
health all over the world. Cancer patient, whose immunity is often compromised, faces a …
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non …
SF Oosting, AAM van der Veldt… - The Lancet …, 2021 - thelancet.com
Background Patients with cancer have an increased risk of complications from SARS-CoV-2
infection. Vaccination to prevent COVID-19 is recommended, but data on the …
infection. Vaccination to prevent COVID-19 is recommended, but data on the …
[HTML][HTML] Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis
S Tran, TH Truong, A Narendran - European journal of cancer, 2021 - Elsevier
Background Efficacy and safety data of COVID-19 vaccines among cancer populations have
been limited; however, preliminary data from recent studies have emerged regarding their …
been limited; however, preliminary data from recent studies have emerged regarding their …
CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2
L Jin, Z Li, X Zhang, J Li, F Zhu - Human vaccines & …, 2022 - Taylor & Francis
CoronaVac, also known as the Sinovac inactivated SARS-CoV-2 vaccine, has been widely
implemented in combating the COVID-19 pandemic. We summarized the results of clinical …
implemented in combating the COVID-19 pandemic. We summarized the results of clinical …
Attitudes of patients with cancer towards vaccinations—results of online survey with special focus on the vaccination against COVID-19
A Brodziak, D Sigorski, M Osmola, M Wilk… - Vaccines, 2021 - mdpi.com
Recently developed COVID-19 vaccines significantly reduce the risk of severe coronavirus
disease, which is essential in the particularly vulnerable cancer patient population. There is …
disease, which is essential in the particularly vulnerable cancer patient population. There is …
[HTML][HTML] Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: should humoral responses be monitored? A position article
J Barrière, M Carles, C Audigier-Valette, D Re… - European Journal of …, 2022 - Elsevier
Taking into account higher risk of severe coronavirus disease 2019 or death among patients
with cancer, as well as impaired immunogenicity after anti-SARS-CoV-2 vaccines, in …
with cancer, as well as impaired immunogenicity after anti-SARS-CoV-2 vaccines, in …
[HTML][HTML] COVID-19 vaccines in adult cancer patients with solid tumours undergoing active treatment: Seropositivity and safety. A prospective observational study in …
L Cavanna, C Citterio, C Biasini, S Madaro… - European journal of …, 2021 - Elsevier
Introduction Patients with cancer are presumed a frail group at high risk of contracting
coronavirus disease (COVID-19), and vaccination represents a cornerstone in addressing …
coronavirus disease (COVID-19), and vaccination represents a cornerstone in addressing …
Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review …
M Tagliamento, E Agostinetto, M Bruzzone… - Critical reviews in …, 2021 - Elsevier
Background A systematic review and meta-analysis was performed to estimate mortality in
adult patients with solid or hematological malignancies and SARS-CoV-2 infection. Methods …
adult patients with solid or hematological malignancies and SARS-CoV-2 infection. Methods …
COVID-19 vaccines in cancer patients. Seropositivity and safety. Systematic review and meta-analysis
L Cavanna, C Citterio, I Toscani - Vaccines, 2021 - mdpi.com
Patients with cancer are among the most vulnerable groups of the COVID-19 pandemic,
whereas vaccinations can represent a cornerstone in overcoming the pandemic itself …
whereas vaccinations can represent a cornerstone in overcoming the pandemic itself …